Kevin Lindsey Thomas, MD

Associate Professor of Medicine
Vice Dean for Diversity, Equity and Inclusion
Member in the Duke Clinical Research Institute
Campus mail Dept of Medicine, Durham, NC 27710
Phone (919) 668-2688
Email address kevin.thomas@duke.edu
In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2004 - 2007
  • Chief Resident in Medicine (DUMC), Medicine, Duke University, 2003 - 2004
  • Fellow in Cardiology, Medicine, Duke University, 2002 - 2003
  • Resident in Medicine, Medicine, Duke University, 1999 - 2002
  • M.D., University of North Carolina - Chapel Hill, 1999

Publications

Piccini, Jonathan P., Adrian F. Hernandez, David Dai, Kevin L. Thomas, William R. Lewis, Clyde W. Yancy, Eric D. Peterson, Gregg C. Fonarow, and Gregg C. Get With the Guidelines Steering Committee and Hospitals. “Use of cardiac resynchronization therapy in patients hospitalized with heart failure.” Circulation 118, no. 9 (August 26, 2008): 926–33. https://doi.org/10.1161/CIRCULATIONAHA.108.773838.

PMID
18697821
Full Text

Piccini, Jonathan P., Adrian F. Hernandez, David Dai, Kevin L. Thomas, William R. Lewis, Clyde W. Yancy, Eric D. Peterson, and Gregg C. Fonarow. “Utilization of cardiac resynchronization therapy in patients hospitalized with heart failure.” In Circulation, 117:E452–E452. LIPPINCOTT WILLIAMS & WILKINS, 2008.

Scholars@Duke

Prisant, L Michael, Kevin L. Thomas, Eldrin F. Lewis, Zhen Huang, Gary S. Francis, W Douglas Weaver, Marc A. Pfeffer, John J. V. McMurray, Robert M. Califf, and Eric J. Velazquez. “Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.” J Am Coll Cardiol 51, no. 19 (May 13, 2008): 1865–71. https://doi.org/10.1016/j.jacc.2007.12.050.

PMID
18466801
Full Text

Thomas, Kevin L., Sana M. Al-Khatib, Yuliya Lokhnygina, Scott D. Solomon, Lars Kober, John J. V. McMurray, Robert M. Califf, and Eric J. Velazquez. “Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.” Am Heart J 155, no. 1 (January 2008): 87–93. https://doi.org/10.1016/j.ahj.2007.09.010.

PMID
18082495
Full Text

Al-Khatib, S. M., G. D. Sanders, M. Carlson, A. Cicic, A. Curtis, G. C. Fonarow, P. W. Groeneveld, et al. “Preventing tomorrow's sudden cardiac death today. Dissemination of effective therapies for sudden cardiac death prevention.” American Heart Journal, 2008.

Scholars@Duke

Mills, J. S., G. L. Adams, P. Tricoci, C. Melloni, E. M. Joliceur, T. W. Wang, and K. L. Thomas. “Highlights from the 20th Scientific Sessions of the American Heart Association: November 12 to 15, 2006, Chicago, Illinois.” American Heart Journal 153, no. 2 (February 1, 2007): 213–23. https://doi.org/10.1016/j.ahj.2006.12.001.

Full Text

Echols, Melvin R., G Michael Felker, Kevin L. Thomas, Karen S. Pieper, Jyotsna Garg, Michael S. Cuffe, Mihai Gheorghiade, Robert M. Califf, and Christopher M. O’Connor. “Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.” J Card Fail 12, no. 9 (December 2006): 684–88. https://doi.org/10.1016/j.cardfail.2006.08.003.

PMID
17174228
Full Text

Thomas, Kevin L., L. M. Prisant, Eldrin F. Lewis, Zhen Huang, Gary S. Francis, W. D. Weaver, Marc A. Pfeffer, John J. McMurray, Robert M. Califf, and Eric J. Velazquez. “Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.” Circulation 114, no. 18 (October 31, 2006): 671–671.

Scholars@Duke

Pages